I-SPY TRIAL: Neoadjuvant and Personalized Adaptive Novel Agents to Treat Breast Cancer

I-SPY TRIAL: Neoadjuvant and Personalized Adaptive Novel Agents to Treat Breast Cancer

University of Alabama at Birmingham

Birmingham, Alabama, United States, 35294

Principal Investigator: Erica Stringer-Reasor, MD         

Mayo Clinic – Scottsdale

Scottsdale, Arizona, United States, 85259

Contact    507-538-7623      

Principal Investigator: Donald Northfelt, MD         

University of Arizona

Tucson, Arizona, United States, 85724

City of Hope

Duarte, California, United States, 91010

Contact    800-826-4673      

Principal Investigator: Yuan Yuan, MD, PhD         

University of California San Diego

La Jolla, California, United States, 92093-0698

Contact    858-822-6194      

Contact    858-822-6194    CancerCTO@ucsd.edu   

Principal Investigator: Anne Wallace, MD         

University of Southern California

Los Angeles, California, United States, 90033

Contact: Kristy Watkins, RN    323-865-0452    Watkins_K@ccnt.usc.edu   

Principal Investigator: Julie Lang, MD         

HOAG Memorial Hospital Presbyterian

Newport Beach, California, United States, 92663

Principal Investigator: Chaitali Nangia, MD         

University of California San Francisco (UCSF)

San Francisco, California, United States, 94115

Contact    415-443-4296      

Principal Investigator: Amy Jo Chien, MD         

University of Colorado

Aurora, Colorado, United States, 80045

Contact    720-848-1622      

Principal Investigator: Anthony Elias, MD         

Yale Cancer Center

New Haven, Connecticut, United States, 06510

Contact: Trisha Burello, MS    203-737-2848    trisha.burrello@yale.edu   

Sub-Investigator: Tara Snaft, MD         

Sub-Investigator: Lajos Pusztai, MD         

Georgetown University Medical Center

Washington, District of Columbia, United States, 20007

Contact: Minetta Liu, MD    202-444-3677    Liumc@georgetown.edu   

Principal Investigator: Claudine Isaacs, MD         

Moffitt Cancer Center

Tampa, Florida, United States, 33612

Principal Investigator: Heather Han, MD         

Emory University

Atlanta, Georgia, United States, 30322

Contact: Greta Green    404-778-3575    ggreen6@emory.edu   

Principal Investigator: Toncred Styblo, MD         

Winship Cancer Institute of Emory University

Atlanta, Georgia, United States, 30322

Principal Investigator: Kevin Kalinsky, MD         

University of Chicago

Chicago, Illinois, United States, 60453

Contact    773-834-2756      

Principal Investigator: Rita Nanda, MD         

Loyola University

Maywood, Illinois, United States, 60153

Contact    708-327-3102      

Principal Investigator: Kathy S Albain, MD         

University of Kansas

Westwood, Kansas, United States, 66205

Herbert-Herman Cancer Center, Sparrow Hospital

Lansing, Michigan, United States, 48912

Principal Investigator: Brittani Thomas, DO         

University of Minnesota

Minneapolis, Minnesota, United States, 55455

Contact    612-626-8487      

Principal Investigator: Douglas Yee, MD         

Mayo Clinic

Rochester, Minnesota, United States, 55905

Contact    507-538-7623      

Principal Investigator: Judy C Boughey, MD         

Rutgers Cancer Institute of New Jersey

New Brunswick, New Jersey, United States, 08903

Contact    732-235-7356      

Principal Investigator: Coral Omene, MD, PhD         

Montefiore Medical Center

Bronx, New York, United States, 10467

Principal Investigator: Jesus D Anampa         

Columbia University Medical Center

New York, New York, United States, 10032

Principal Investigator: Meghana Trivedi, MD         

University of Rochester Wilmot Cancer Institute

Rochester, New York, United States, 14642

Contact       WCICTOResearch@urmc.rochester.edu   

Principal Investigator: Carla Folksm, MD         

Wake Forest Baptist Comprehensive Cancer Center

Winston-Salem, North Carolina, United States, 27157

Contact: Angela Howell, MD    336-716-5440    anhowell@wakehealth.edu   

Principal Investigator: Alexandra Thomas, MD         

Cleveland Clinic

Cleveland, Ohio, United States, 44106

Contact    800-233-2273      

Principal Investigator: Erin Roesch, MD         

Oregon Health & Science Institute (OHSU)

Portland, Oregon, United States, 97239

Contact: Taylor Knapp    503-494-4438    knappt@ohsu.edu   

Contact    503-494-8573      

Principal Investigator: Evie Hobbs, MD         

University of Pennsylvania (U Penn)

Philadelphia, Pennsylvania, United States, 19104

Contact    215-614-1850      

Principal Investigator: Amy Clark, MD         

University Pittsburgh Medical Center

Pittsburgh, Pennsylvania, United States, 15213

Sanford Clinical Research

Sioux Falls, South Dakota, United States, 57104

Principal Investigator: Amy Sanford, MD         

Vanderbilt University Medical Center

Nashville, Tennessee, United States, 27204

Principal Investigator: Ingrid Mayer, MD         

University of Texas, Southwestern Medical Center

Dallas, Texas, United States, 75390-9155

University of Texas, M.D. Anderson Cancer Center

Houston, Texas, United States, 77230-1439

Inova Health System

Falls Church, Virginia, United States, 22042

Swedish Cancer Institute

Seattle, Washington, United States, 98104

University of Washington

Seattle, Washington, United States, 98115

Source: View full study details on ClinicalTrials.gov

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. By listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details.

November 23, 2022Comments OffClinicalTrials.gov | Endocrinology Clinical Trials | Endocrinology Studies | US National Library of Medicine